Quick answer: The BDI-II (Beck Depression Inventory-II) is a 21-item self-report depression measure scored 0–63. Severity bands: 0–13 minimal, 14–19 mild, 20–28 moderate, 29–63 severe. A score ≥14 indicates at least mild depression and warrants clinical follow-up — the BDI-II measures symptom severity, not diagnosis.
Interactive Beck Score Calculator
Enter the total score from your administered BDI-II (Beck Depression Inventory-II) — get the severity band and a SOAP-ready summary
Free AI screening
Neuraline's free PHQ-9 and GAD-7 AI screening tools auto-score depression and anxiety in seconds — try them free in the live demo.
Educational interpreter only — this tool does not reproduce Beck inventory test items. Bands are the standard published severity ranges; interpretation requires the administering clinician.
What Is the BDI-II?
The BDI-II (Beck Depression Inventory-II) is the current revision of the original Beck Depression Scale that Aaron T. Beck introduced in 1961 — the instrument that established the idea of quantifying depressive symptom severity with a standardized self-report. The 1996 revision rewrote the somatic items (sleep, appetite, fatigue, concentration) to reduce confounding with medical illness and aligned item content with contemporary diagnostic thinking, producing the 21-item form used today.
Each item presents four graded statements rated 0–3, covering the full symptom surface of depression: affective (sadness, crying, loss of pleasure), cognitive (pessimism, guilt, self-dislike, failure), somatic/vegetative (sleep, appetite, fatigue, concentration), and motivational (withdrawal, indecisiveness, loss of energy). Patients complete it in roughly 5–10 minutes.
One practical constraint separates the BDI-II from most screens in this library: it is copyrighted by Pearson, and clinical use requires purchasing licensed record forms or scoring software — per-use costs that scale with patient volume. That economic fact is the main reason the free-to-use PHQ-9 displaced it in most US primary-care workflows, while psychiatry practices, specialty clinics, and clinical trials retain the BDI-II for its granular severity tracking and decades of research comparability. (Full head-to-head: BDI-II vs PHQ-9.)
BDI-II Scoring: 0–63 Total
Scoring is a straight sum — there are no reverse-scored items and no subscale corrections:
| Step | Calculation |
|---|---|
| Item scores | Each of the 21 items rated 0, 1, 2, or 3 |
| Total score | Sum of all 21 items |
| Possible range | 0 (no symptoms) to 63 (all symptoms at maximum severity) |
Two scoring rules that matter in practice: first, the total is only interpretable when the form was completed in full — a skipped item understates severity, so verify completeness before banding; second, the BDI-II is a severity snapshot of the past two weeks, so time the administration relative to treatment changes accordingly. Item 9 (thoughts of death or suicide) deserves individual review regardless of the total — any nonzero endorsement triggers a suicide risk assessment independent of the band.
Severity Bands & Interpretation
| Band | Score | Clinical meaning |
|---|---|---|
| Minimal | 0–13 | No significant depressive symptoms |
| Mild | 14–19 | Mild depression — monitor or brief intervention |
| Moderate | 20–28 | Moderate depression — treatment indicated |
| Severe | 29–63 | Severe depression — active treatment, safety assessment |
The bands are Beck's published severity ranges, and each is a decision point rather than a label. Minimal (0–13) generally needs no intervention beyond routine monitoring — though a rising trend across visits is itself a signal. Mild (14–19) supports watchful waiting, psychoeducation, or brief behavioral activation, with repeat scoring in 2–4 weeks. Moderate (20–28) is the typical treatment-initiation zone — psychotherapy, pharmacotherapy, or both, depending on history and preference. Severe (29–63) calls for active treatment optimization and, because scores this high correlate with impaired function and elevated suicide risk, an explicit safety review.
Interpretation caveats: the BDI-II is a severity measure, not a diagnostic instrument — a positive score warrants a clinical interview against DSM-5-TR criteria before a diagnosis is assigned. Scores can also be inflated by medical illness, grief, or substance use; the 1996 revision reduced but did not eliminate somatic confounding, so read the somatic items alongside the medical picture.
Documenting the Score in a Psychiatric SOAP Note
A complete BDI-II entry in the assessment section gives the score, the band, the trend, and the safety read:
Assessment: Patient completed the BDI-II at today's visit; total 24/63 — moderate range (band 20–28). Down from baseline 31/63 (severe) on 10/06, consistent with partial response to sertraline 100 mg. Item 9 (suicidal thoughts) endorsed 0; no acute safety concerns. Somatic items (sleep, fatigue) remain elevated relative to cognitive items.
Plan: Continue sertraline 100 mg; add CBT referral. Repeat BDI-II in 4 weeks to track response — target is ≥50% reduction or return to minimal band. CPT 96127 billed for staff-administered scoring.
That structure — score, band, trend, safety, plan — is what reviewers and consultants look for, and it converts directly into measurement-based-care tracking.
Administration & Billing Notes
- CPT 96127 (brief emotional/behavioral assessment) covers scoring and reporting of validated instruments like the BDI-II when staff administer and score them — document the instrument, the score, the scorer, and the administration date. Medicare's national average reimbursement runs roughly $1.50–$3 per administration; most payers allow up to 4 units per day.
- ICD-10 linkage: band the score to the working diagnosis — F32.x for a depressive episode (F32.1 moderate, F32.2 severe) or F33.x for recurrent depression. The score supports severity selection; it does not by itself establish the code.
- Serial cadence: administer every 2–4 weeks during active treatment. Many protocols define response as a ≥50% reduction from baseline and remission as a return to the minimal band (≤13) — record both the raw score and the band at every administration so the trajectory is auditable.
FAQs
What is a normal BDI-II score? Scores of 0–13 fall in the minimal range and are generally considered normal — no clinically significant depressive symptoms. There is no single "normal" value below 14; a score of 12 with a rising trend across visits still deserves attention, while a stable 8 in a patient under active treatment is a good sign.
Is the BDI-II the same as the Beck Depression Scale? Yes — the Beck Depression Scale, BDI, BDI-IA, and BDI-II all refer to the Beck family of depression inventories. The BDI-II (1996) is the current version in clinical use; older published cutoffs from the original BDI differ slightly, so always score against the version actually administered.
What does a BDI-II score of 20 mean? A score of 20 falls in the moderate band (20–28) — depression severity at which active treatment is indicated, typically psychotherapy, medication, or both. It sits just above the mild/moderate boundary, so it is also a common threshold for initiating or intensifying treatment in measurement-based-care protocols.
Can the BDI-II diagnose depression? No. The BDI-II quantifies symptom severity; diagnosis requires a clinical interview applying DSM-5-TR criteria, including duration, functional impairment, and rule-outs (medical illness, substance use, bereavement). Use the score to support and document the diagnostic impression — not to replace it.
Automate Depression Screening with Neuraline
The BDI-II's licensing fees are exactly why most US clinics screen with the PHQ-9 — free to use, 9 items, 3 minutes — and pair it with the GAD-7 for anxiety. Neuraline's AI Screening administers the PHQ-9 and GAD-7 automatically before the appointment through Digital Forms sent via the patient portal, scores them instantly, flags item-9 suicide risk, and files the result straight into the chart — no staff scoring time, no per-use fees. See it running in the live demo, or start with the PHQ-9 scoring guide and GAD-7 scoring guide.
